Normal serum uric acid concentrations in women with polycystic ovary syndrome

Human Reproduction

Volumn 11, Issue 11, 1996, Pages 2405-2407

  Anttila, L ^a   Rouru, J ^b   Penttila T ^a   Irjala, K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome; Serum urine acid

Indexed keywords

HORMONE BINDING PROTEIN; INSULIN; TESTOSTERONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; SCREENING TEST; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0030475363     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019124     Document Type: Article

References (21)

1. Adams, J., Poison, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-359.
2. Anttila, L., Koskinen, P., Irjala, K. et al. (1991) Reference intervals for serum sex steroids and gonadotropins in regularly menstruating women. Acta Obstet. Gynecol., 70, 475-481.
3. Anttila, L., Koskinen, P., Kaihola, H.-L. et al. (1992) Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries. Fertil. Steril., 58, 697-702.
4. Anttila, L., Koskinen, P., Jaatinen ,T.-A. et al. (1993) Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum. Reprod., 8, 1179-1183.
5. Clayton, R.N., Ogden, V., Hodgkinson, J. et al. (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol., 37, 127-134.
6. Conway, G.S., Agrawal, R., Betteridge, D.J. et al. (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin. Endocrinol., 37, 119-125.
7. Dahlgren. E., Johansson, S., Lindstedt, G. et al. (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil. Steril., 57, 505-513.
8. Dunaif, A. (1993) Insulin resistance and ovarian dysfunction. In Moller. D.E. (ed.), Insulin Resistance. John Wiley & Sons, Chichester, pp. 301-325.
9. Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853-861.
10. Holte, J., Berg, T., Berne, C. et al. (1994) Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric. endocrine and metabolic variables. Clin. Endocrinol., 41, 463-471.
11. Holte, J., Berg, T., Berne, C. et al. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 2586-2593.
12. Korytkowski, M.T., Mokan, M., Horwitz, M.J. et al. (1995) Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 3327-3334.
13. Nestler, J.E. (1993) Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J. Clin. Endocrinol. Metab., 76, 273-274.
14. Norman, R.J., Hague, W.M., Masters, S.C. and Wang, X.J. (1995) Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum. Reprod., 10, 2258-2261.
15. Polson, D.W., Wadsworth, J., Adams, J. et al. (1988) Polycystic ovaries-common finding in normal women. Lancet, i, 870-872.
16. Prelevic, G.M., Wurzburger, M.I., Balint-Peric, L. et al. (1992) Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Harm. Res., 37, 125-131.
17. Reaven, G.M. (1994) Syndrome X: 6 years later. J. Int. Med., 236, 13-22.
18. Robinson, S., Henderson, A.D., Gelding, S.V. et al. (1996) Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin. Endocrinol., 44, 277-284.
19. Vuorinen-Markkola, H. and Yki-Järvinen, H. (1995) Hyperuricemia and insulin resistance. J. Clin. Endocrinol. Metab., 78, 25-29.
20. Wild, R.A. (1995) Hyperandrogenism: implications for cardiovascular disease. In Redmond, G.P. (ed.), Androgenic Disorders. Raven Press, New York, pp. 261-278.
21. Wild, R.A., Painter, P.C., Coulson. P.B. et al. (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 61, 946-951.